Your browser doesn't support javascript.
loading
High-frequency spinal cord stimulation in failed back surgery syndrome patients with predominant low back pain-single-center experience.
Motov, Stefan; Aftahy, Kaywan; Jörger, Ann-Kathrin; Wagner, Arthur; Meyer, Bernhard; Shiban, Ehab.
Afiliación
  • Motov S; Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany. stefanmotov@yahoo.de.
  • Aftahy K; Department of Neurosurgery, University hospital of Augsburg, Augsburg, Germany. stefanmotov@yahoo.de.
  • Jörger AK; Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
  • Wagner A; Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
  • Meyer B; Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
  • Shiban E; Department of Neurosurgery, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany.
Neurosurg Rev ; 44(5): 2809-2818, 2021 Oct.
Article en En | MEDLINE | ID: mdl-33454835
Treatment of patients with failed back surgery syndrome (FBSS) with predominant low back pain (LBP) remains challenging. High-frequency spinal cord stimulation (HF10 SCS) is believed to achieve significant pain reduction. We aimed to evaluate the real-life efficacy of HF-10 SCS in a tertiary spine center. A prospective observational study of all patients with FBSS and predominant LBP who underwent HF-10 SCS surgery was performed between 2016 and 2018. Patients > 18 years with Visual Analogue Scale (VAS) scores of ≥ 5 for LBP and pain duration > 6 months under stable medication were implanted percutaneous under general anesthesia and a trial phase of 7-14 days was accomplished. Primary end point was a successful trial defined as ≥ 50% VAS score reduction for LBP. Thirty-four of 39 (85%) subjects had a successful trial. Fifty-three percent were female and the mean age was 69 years. Median follow-up lasted for 10 months. Devices were removed after a median of 10 months in 5 cases. Remaining 29 patients stated significant VAS score reduction for LBP from 8.1 to 2.9 and VAS for leg pain from 4.9 to 2.2. Twenty-four percent of all patients were able to discontinue their opioids. Eight of 9 patients (89%) with signs of adjacent disc disease and 7 of 10 (70%) patients with hardware failure were successfully implanted with significant VAS reduction for LBP. HF-10 SCS achieves significant pain reduction in most patients with FBSS and predominant LBP. It might be an efficient alternative to revision surgery.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor de la Región Lumbar / Síndrome de Fracaso de la Cirugía Espinal Lumbar / Estimulación de la Médula Espinal Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Neurosurg Rev Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor de la Región Lumbar / Síndrome de Fracaso de la Cirugía Espinal Lumbar / Estimulación de la Médula Espinal Tipo de estudio: Observational_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Neurosurg Rev Año: 2021 Tipo del documento: Article País de afiliación: Alemania